• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to N.-K.V. Cheung et al.

作者信息

Matthay Katherine K, London Wendy B, Maris John, Adamson Peter C, Park Julie R

机构信息

University of California San Francisco School of Medicine, San Francisco, CA

Dana Farber Cancer Institute and Boston Children's Cancer and Blood Disorders, Boston, MA.

出版信息

J Clin Oncol. 2014 Dec 20;32(36):4174-5. doi: 10.1200/JCO.2014.58.7006. Epub 2014 Nov 17.

DOI:10.1200/JCO.2014.58.7006
PMID:25403223
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5142206/
Abstract
摘要

相似文献

1
Reply to N.-K.V. Cheung et al.对N.-K.V. 张等人的回复
J Clin Oncol. 2014 Dec 20;32(36):4174-5. doi: 10.1200/JCO.2014.58.7006. Epub 2014 Nov 17.
2
When overall survival fails to confirm event-free survival, should the latter be used to set the standard of care?当总生存期未能证实无事件生存期时，后者是否应用于设定护理标准？
J Clin Oncol. 2014 Dec 20;32(36):4173-4. doi: 10.1200/JCO.2014.58.1678. Epub 2014 Nov 17.
3
Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.骨髓和血液中肿瘤细胞的定量含量作为IV期神经母细胞瘤预后的预测指标：一项儿童癌症研究组的研究
J Clin Oncol. 2000 Dec 15;18(24):4067-76. doi: 10.1200/JCO.2000.18.24.4067.
4
Prolonged Isotretinoin in Ultra High-Risk Neuroblastoma.超高危神经母细胞瘤的长期异维甲酸治疗
J Pediatr Hematol Oncol. 2017 Jan;39(1):e33-e35. doi: 10.1097/MPH.0000000000000695.
5
Purged autologous bone marrow transplantation in 25 cases of very poor prognosis neuroblastoma.
Lancet. 1985 Mar 9;1(8428):576-7. doi: 10.1016/s0140-6736(85)91231-0.
6
[Allogeneic bone marrow transplantation in a child with a stage IV neuroblastoma].
Ann Pediatr (Paris). 1984 Oct 15;31(9):787-90.
7
[Intensive chemotherapy followed by autologous bone marrow transplantation in solid tumors in childhood].
Ned Tijdschr Geneeskd. 1984 Dec 8;128(49):2302-5.
8
Autologous bone marrow transplantation for very bad prognosis neuroblastoma.
Prog Clin Biol Res. 1985;175:569-86.
9
Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma.
Prog Clin Biol Res. 1991;366:527-33.
10
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.巩固性放化疗及自体骨髓移植与继续化疗治疗转移性神经母细胞瘤的比较：儿童癌症研究组两项同期研究报告
J Clin Oncol. 1996 Sep;14(9):2417-26. doi: 10.1200/JCO.1996.14.9.2417.

引用本文的文献

1
Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation.GPOH NB97 试验中高危神经母细胞瘤患儿的长期结果比较高剂量化疗联合自体造血干细胞移植和口服化疗作为巩固治疗的疗效。
Br J Cancer. 2018 Aug;119(3):282-290. doi: 10.1038/s41416-018-0169-8. Epub 2018 Jul 11.
2
Tandem high-dose chemotherapy with thiotepa and busulfan-melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients.硫替派与白消安-美法仑联合大剂量化疗及自体干细胞移植用于极高危神经母细胞瘤患者
Bone Marrow Transplant. 2016 Feb;51(2):227-31. doi: 10.1038/bmt.2015.264. Epub 2015 Nov 2.

本文引用的文献

1
When overall survival fails to confirm event-free survival, should the latter be used to set the standard of care?当总生存期未能证实无事件生存期时，后者是否应用于设定护理标准？
J Clin Oncol. 2014 Dec 20;32(36):4173-4. doi: 10.1200/JCO.2014.58.1678. Epub 2014 Nov 17.
2
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.清髓与非清髓外周血造血干细胞移植治疗高危神经母细胞瘤（COG A3973）：一项随机 3 期临床试验。
Lancet Oncol. 2013 Sep;14(10):999-1008. doi: 10.1016/S1470-2045(13)70309-7. Epub 2013 Jul 25.
3
Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma.迈向个体化治疗的进展：神经母细胞瘤的生物和风险导向治疗。
Expert Rev Neurother. 2011 Oct;11(10):1411-23. doi: 10.1586/ern.11.103.
4
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.Anti-GD2 抗体联合 GM-CSF、白细胞介素-2 和异维 A 酸治疗神经母细胞瘤。
N Engl J Med. 2010 Sep 30;363(14):1324-34. doi: 10.1056/NEJMoa0911123.
5
Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.在一项采用清髓性疗法继以13-顺式维甲酸的随机试验中接受治疗的高危神经母细胞瘤患儿的长期结果：一项儿童肿瘤学组研究
J Clin Oncol. 2009 Mar 1;27(7):1007-13. doi: 10.1200/JCO.2007.13.8925. Epub 2009 Jan 26.
6
Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial.高危神经母细胞瘤患者自体干细胞救援的清髓性大剂量疗法与口服维持化疗作为巩固治疗的随机对照试验
Lancet Oncol. 2005 Sep;6(9):649-58. doi: 10.1016/S1470-2045(05)70291-6.
7
High dose melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group.大剂量美法仑治疗晚期神经母细胞瘤：欧洲神经母细胞瘤研究组的一项随机试验（ENSG-1）结果
Pediatr Blood Cancer. 2005 Apr;44(4):348-57. doi: 10.1002/pbc.20219.
8
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.采用强化化疗、放疗、自体骨髓移植及13-顺式维甲酸治疗高危神经母细胞瘤。儿童癌症研究组。
N Engl J Med. 1999 Oct 14;341(16):1165-73. doi: 10.1056/NEJM199910143411601.